Marcel Mohr - Homepage - VERÖFFENTLICHUNGEN

DR. MARCEL MOHR (he/him)

Beiträge in Fachzeitschriften

C. Trovato, M. Mohr, F. Schmidt, E. Passini, B. Rodriguez. Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac Purkinje cells for proarrythmia risk prediction. Front. Toxicol. 4:992650 (2022).
M. Mohr, J. M. Chambard, V. Ballet, F. Schmidt. Accurate in silico simulation of the rabbit Purkinje fiber electrophysiological assay to facilitate early pharmaceutical cardiosafety assessment: Dream or reality? J. Pharmacol. Toxicol. Methods 115: 107172 (2022).
ausgezeichnet mit dem Translational Science Publication Award 2022 der Safety Pharmacology Society
M. Mohr, D. Hose, A. Seckinger, A. Marciniak-Czochra. Quantification of plasma cell dynamics using mathematical modelling. R. Soc. Open Sci. 5: 170759 (2018)
M. Mohr, M. V. Barbarossa, C. Kuttler. Predator-prey interactions, age structures and delay equations. Math. Model. Nat. Phenom. 9(1): 92-107 (2014)

M. Mohr. Mathematical modelling of plasma cell dynamics in multiple myeloma. Dissertation, Universität Heidelberg (2016)
M. Mohr. On predator-prey models with delay due to maturation. Master Thesis, Technische Universität München (2012)
M. Mohr. Das N-Wirbel-Problem. Bachelor Thesis, Universität Gießen (2009)

M. Mohr, D. Hose, A. Seckinger, A. Marciniak-Czochra. Mathematical modeling reveals the dynamics of plasma cells in multiple myeloma. SMB Annual Meeting (2017)
A. Seckinger, A. Jauch, M. Emde, S. Beck, M. Mohr, M. Granzow, T. Hielscher, T. Rème, R. Schnettler, N. Fard, K. Hinderhofer, P. T. Pyl, W. Huber, V. Benes, A. Marciniak-Czochra, V. Pantesco, A. D. Ho, B. Klein, J. Hillengass, D. Hose. Asymptomatic multiple myeloma: Background of progression, evolution, and prognosis. Blood 128: 235 (2016)